Akyso Therapeutics, LLC

Quick facts

Phase 1 pipeline

• Extended-release naltrexone injection, 380 mg
• Naltrexone implant, 14.4 grams
• Naltrexone implant, 9.6 grams

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Akyso Therapeutics, LLC portfolio CI brief
• Akyso Therapeutics, LLC pipeline updates RSS

Related

• Sector hub: All tracked pharma companies